Chavatte P - Search Results

1

Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.

Diouf O, Depreux P, Chavatte P, Poupaert JH. Diouf O, et al. Among authors: chavatte p. Eur J Med Chem. 2000 Jul-Aug;35(7-8):699-706. doi: 10.1016/s0223-5234(00)00163-x. Eur J Med Chem. 2000. PMID: 10960185

2

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

Stern E, Muccioli GG, Millet R, Goossens JF, Farce A, Chavatte P, Poupaert JH, Lambert DM, Depreux P, Hénichart JP. Stern E, et al. Among authors: chavatte p. J Med Chem. 2006 Jan 12;49(1):70-9. doi: 10.1021/jm050467q. J Med Chem. 2006. PMID: 16392793

3

Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds.

Yous S, Lebegue N, Poupaert JH, Chavatte P, Berthelot P. Yous S, et al. Among authors: chavatte p. J Enzyme Inhib Med Chem. 2005 Dec;20(6):525-32. doi: 10.1080/03067310500212037. J Enzyme Inhib Med Chem. 2005. PMID: 16408788 Free article.

4

Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.

Garofalo A, Farce A, Ravez S, Lemoine A, Six P, Chavatte P, Goossens L, Depreux P. Garofalo A, et al. Among authors: chavatte p. J Med Chem. 2012 Feb 9;55(3):1189-204. doi: 10.1021/jm2013453. Epub 2012 Jan 25. J Med Chem. 2012. PMID: 22229669

5

Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.

Wallez V, Durieux-Poissonnier S, Chavatte P, Boutin JA, Audinot V, Nicolas JP, Bennejean C, Delagrange P, Renard P, Lesieur D. Wallez V, et al. Among authors: chavatte p. J Med Chem. 2002 Jun 20;45(13):2788-800. doi: 10.1021/jm0005252. J Med Chem. 2002. PMID: 12061881

6

Synthesis and pharmacological evaluation of analgesic 6-substituted 2(3H)-benzothiazolones.

Yous S, Poupaert JH, Chavatte P, Espiard JG, Caignard DH, Lesieur D. Yous S, et al. Among authors: chavatte p. Drug Des Discov. 2001;17(4):331-6. Drug Des Discov. 2001. PMID: 11765136

7

Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.

Descamps-François C, Yous S, Chavatte P, Audinot V, Bonnaud A, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Descamps-François C, et al. Among authors: chavatte p. J Med Chem. 2003 Mar 27;46(7):1127-9. doi: 10.1021/jm0255872. J Med Chem. 2003. PMID: 12646022

8

Novel structural insights for drug design of selective 5-HT(2C) inverse agonists from a ligand-biased receptor model.

Renault N, Gohier A, Chavatte P, Farce A. Renault N, et al. Among authors: chavatte p. Eur J Med Chem. 2010 Nov;45(11):5086-99. doi: 10.1016/j.ejmech.2010.08.018. Epub 2010 Aug 12. Eur J Med Chem. 2010. PMID: 20880612

9

Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.

Houssin R, Pommery J, Salaün MC, Deweer S, Goossens JF, Chavatte P, Hénichart JP. Houssin R, et al. Among authors: chavatte p. J Med Chem. 2002 Jan 17;45(2):533-6. doi: 10.1021/jm010297r. J Med Chem. 2002. PMID: 11784157

10

Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.

Ettaoussi M, Péres B, Klupsch F, Delagrange P, Boutin JA, Renard P, Caignard DH, Chavatte P, Berthelot P, Lesieur D, Yous S. Ettaoussi M, et al. Among authors: chavatte p. Bioorg Med Chem. 2008 May 1;16(9):4954-62. doi: 10.1016/j.bmc.2008.03.036. Epub 2008 Mar 17. Bioorg Med Chem. 2008. PMID: 18372181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters